Axsome: Q1 Earnings Snapshot
Axsome Therapeutics Inc. (AXSM) on Monday reported a loss of $11.2 million in its first quarter
By AP News
Published - May 08, 2023, 07:18 AM ET
Last Updated - May 02, 2024, 02:46 PM EDT
NEW YORK (AP) — NEW YORK (AP) — Axsome Therapeutics Inc. (AXSM) on Monday reported a loss of $11.2 million in its first quarter.
On a per-share basis, the New York-based company said it had a loss of 26 cents. Losses, adjusted for amortization costs, came to 22 cents per share.
The results surpassed Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of $1.13 per share.
The biopharmaceutical company posted revenue of $94.6 million in the period, also exceeding Street forecasts. Eight analysts surveyed by Zacks expected $26.9 million.
